ArticleBMJ (Clinical research ed.)2022

Agreement of treatment effects from observational studies and randomized controlled trials evaluating hydroxychloroquine, lopinavir-ritonavir, or dexamethasone for covid-19: meta-epidemiological study.

Osman Moneer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.